Cancer Stem Cell High-Throughput Drug Screening Study
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
A study to determine the safety of CSC/ HTS-based combination drug therapy in subjects who
have GBM that has recurred or progressed following prior radiation therapy and TMZ.